Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 401

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 401
---
 |     |             |                           31 |     |                |    92 |     |       |    123 |     |             |                           15 |     |                |    185 |   |     |       |    200 |   |
| Insurance and Other             |     |             |                           68 |     |                | 1,055 |     |       |  1,123 |     |             |                           58 |     |                |  1,356 |   |     |       |  1,414 |   |
| Research and development—Direct |     |             |                        4,255 |     |                |     — |     |       |  4,255 |     |             |                        6,782 |     |                |      — |   |     |       |  6,782 |   |
| Office Expenses                 |     |             |                           19 |     |                |   268 |     |       |    287 |     |             |                           51 |     |                |    323 |   |     |       |    374 |   |
| Taxes                           |     |             |                            — |     |                |     1 |     |       |      1 |     |             |                            9 |     |                |   (352 | ) |     |       |   (343 | ) |
| Depreciation                    |     |             |                            — |     |                |     — |     |       |      — |     |             |                            — |     |                |      9 |   |     |       |      9 |   |
| Total operating expenses        |     | $           |                        5,387 |     | $              | 8,145 |     | $     | 13,532 |     | $           |                        9,023 |     | $              | 12,142 |   |     | $     | 21,165 |   |

F-147

#### KINETA, INC.

### Notes to Consolidated Financial Statements

#### Entity-Wide Disclosures
In addition to the segment information, the Company provides entity-wide disclosures about its products and services, geographic areas, and major customers. The Company did not generate revenue for the year ended December 31, 2024 and generated license and collaboration revenue from one customer located in the United States for the year ended December 31,